Arkolith/Insider Trading/AVXL/Form 4

Skarpelos Athanasios

DirectorANAVEX LIFE SCIENCES CORP. (AVXL) · full profile →Form 4 · filed May 27, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$453K
Net Open-Market Flow
-$453K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 25, 2022Option exercise(M)50K$0.92$46K1.4M
May 25, 2022Sell(S)50K$9.06$453K1.3M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 25, 2022Option exercise(M)50K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001731122-22-001013) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML